1. A. N. Ellepola, and L. P. Samaranayake. Antimycotic
agents in oral candidiasis: an overview: Clinical
variants, Dent. Update. 27: 111–116 (2000).
2. H. A. Albougy and S. Naidoo. A systematic review of
the management of oral candidiasis associated with
HIV/AIDS, SADJ. 57:457–466 (2002).
3. E. D. Pienaar, T. Young, and H. Holmes.
Interventions for the prevention and management
of oropharyngeal candidiasis associated with HIV
infection in adults and children, Cochrane Database
Syst. Rev. 3: CD003940 (2006).
4. E. Anaissie. Opportunistic mycoses in the
immunocompromised host: experience at a cancer
center and review, Clin. Infect. Dis. 14 (suppl 1):
S43–S53 (1992).
5. J. V. Roey, M. Haxaire, M. Kamya, I. Lwanga, and E.
Katabira. Comparative efficacy of topical therapy
with a slow release mucoadhesive buccal tablet
containing miconazole nitrate versus systemic
therapy with ketoconazole in HIV-positive patients
with oropharyngeal candidiasis, J. Acquir. Immune
Defic. Syndr. 35: 144–150 (2004).
6. S. Bouckaert, and J. P. Remon. In-vitro bioadhesion
of a buccal, miconazole slow release tablet, J. Pharm.
Pharmacol. 45: 504–507 (1993).
7. T. Save and P. Venkitachalam. Buccoadhesive tablets
of nifedipine in standardization of a novel
buccoadhesive erodible carrier, Drug Dev. Ind.
Pharm. 20: 3005–3014 (1994).
8. S. Singh, S. Jain, M. S. Muthu, S. Tiwari, and R. Tilak.
Preparation and Evaluation of Buccal Bioadhesive
Films Containing Clotrimazole, AAPS PharmSciTech,
Vol. 9, No. 2, (2008).
9. N. A. Nafee, F. A. Ismail, N. A. Boraie, and L. M.
Mortada. Mucoadhesive buccal patches of
miconazole nitrate: in vitro/in vivo performance
and effect of ageing, Int. J. Pharm. 1–2: 1–14 (2003).
10. B. Parodi, E. Russo, G. Caviglioli, S. Cafaggi, G.
Bignardi. Development and characterization of a
buccoadhesive dosage form of oxycodone
Milan et al., ARPB, 2013; Vol 3 (I) ISSN 2250-0774
(RESEARCH ARTICLE)
365 | P a g e w w w . a r p b . i n f o
hydrochloride, Drug Dev. Ind. Pharm. 22: 445-50
(1996).
11. K. K. Peh, and C. F. Wong. Polymeric films as vehicle
for buccal delivery: swelling, mechanical, and
bioadhesive properties, J. Pharm. Pharmaceut. Sci.
2: 53–61 (1999).
12. R. Gurny, J. M. Meyer and N. A. Peppas. Bioadhesive
intraoral release systems: design, testing and
analysis, Biomaterials 5: 336-340 (1984).
13. A. Gursoy, I. Sohtorik, N. Uyanik and N. A. Peppas.
Mucoadhesive controlled release systems for
vaginal delivery, STP Pharma 5: 886-892 (1989).
14. G. Levy. Effect of certain tablet formulation factors
on dissolution rate of the active ingredients, J.
Pharm. Sci., 52: 1039-51 (1963).
15. M. S. El-Samaligy, S. A. Yahia, E. B. Basalious.
Formulation and evaluation of diclofenac sodium
buccoadhesive discs, Int. J. Pharm. 286: 27-39
(2004).
16. R. Khanna, S. P. Agarwal, and A. Ahuja.
Mucoadhesive buccal tablets of clotrimazole for oral
candidiasis, Drug Dev. Ind. Pharm. 23: 831–837
(1997).
17. M. R. Rachh, B. S. Barot, P. B. Parejiya, P. K. Shelat
and S. S. Deshpande. Formulation and
Characterization of Ciclopirox olamine
mucoadhesive effervescent tablets for vaginal
delivery, International Journal of Pharmaceutical
Sciences and Nanotechnology. Vol. 5 (4): 1903-
1913 (2013).
18. P. B. Parejiya, B. S. Barot, H. K. Patel, P. K. Shelat, A.
K. Shukla. Development of platform technology for
oral controlled delivery of highly water soluble
drugs using milnacipran HCl as a model drug, Drug
Deliv Lett, 2 (1): 35-45 (2012).
19. S. Anlar, Y. Capan, A. Hincal. Physico-chemical and
bioadhesive properties of polyacrylic acid polymers,
Pharmazie, 48: 285- 7 (1993).
20. N. A Nafee, F. A. Ismail, N. A. Boraie, L. M. Mortada.
Mucoadhesive buccal patches of miconazole nitrate:
in vitro/in vivo performance and effect of ageing,
Int. J. Pharm., 264: 1-14 (2003).
21. C. F. Rodriguez, N. Bruneau, J. Barra, D. Alfonso, E.
Doelker. In Handbook of Pharmaceutical Controlled
Release Technology, Wise, D. L., Ed.; Marcell Dekker:
New York, 2000, Vol. 1, pp. 1-30.
Thank you for copying data from http://www.arastirmax.com